These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11255674)

  • 21. Clotting factor concentrates.
    Entwistle CC
    Int Anesthesiol Clin; 1985; 23(2):49-59. PubMed ID: 3924836
    [No Abstract]   [Full Text] [Related]  

  • 22. Present state and perspectives of the farctionation of human plasma, serum and placenta.
    Richter P
    Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
    [No Abstract]   [Full Text] [Related]  

  • 23. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
    Linke T; Doraiswamy S; Harrison EH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):273-81. PubMed ID: 17188586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why prescribe highly purified factor VIII and IX concentrates?
    Berntorp E
    Vox Sang; 1996; 70(2):61-8. PubMed ID: 8801765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of dengue virus in the plasma-derived therapeutic proteins.
    Xie YW; Chan PK; Szeto CK; Kwok SY; Chu IM; Chu SS; Cheung JL; Wong SW; Ali MB; Wong BL
    Transfusion; 2008 Jul; 48(7):1342-7. PubMed ID: 18315529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants.
    Chin S; Williams B; Gottlieb P; Margolis-Nunno H; Ben-Hur E; Hamman J; Jin R; Dubovi E; Horowitz B
    Blood; 1995 Dec; 86(11):4331-6. PubMed ID: 7492794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor plasmapheresis and regional self sufficiency.
    Urbaniak SJ
    Int J Artif Organs; 1984 Jan; 7(1):43-6. PubMed ID: 6421755
    [No Abstract]   [Full Text] [Related]  

  • 28. Removal and inactivation of hepatitis B virus from contaminated pooled plasma in a large-scale manufacturing process for factor VIII and human serum albumin.
    Murozuka T; Aoki M; Kimura N; Sotoyama K; Abe I; Izumi H; Emura H; Takeda Y; Nanakawa H; Katsubayashi Y; Takeuchi T; Ito H; Hirakawa S; Mitsunaga S; Tadokoro K; Kanemitsu K; Miyamoto M; Yamanaka R; Nishioka K
    Vox Sang; 1999; 76(3):181-6. PubMed ID: 10341335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of human plasma fibrinogen by chromatography on protamine-agarose.
    Dempfle CE; Heene DL
    Thromb Res; 1987 Apr; 46(1):19-27. PubMed ID: 3590112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The isolation of alpha 1-proteinase inhibitor from the byproducts of the manufacture of blood products].
    Novikova LI; Kulikova NN; Aleshkin VA
    Gematol Transfuziol; 1989 Dec; 34(12):46-50. PubMed ID: 2628154
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin and haemostasis: regulation of the biological functions of thrombin. (Facts and perspectives).
    Machovich R; Horváth I
    Haematologia (Budap); 1981 Dec; 14(4):339-59. PubMed ID: 6178655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current approaches to the preparation of plasma fractions.
    Vandersande J
    Biotechnology; 1991; 19():165-76. PubMed ID: 1786470
    [No Abstract]   [Full Text] [Related]  

  • 34. Affinity chromatography to remove viruses during preparation of plasma derivatives.
    Lawrence JE
    Dev Biol Stand; 1993; 81():191-7. PubMed ID: 8174803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high-capacity hydrophobic adsorbent for human serum albumin.
    Belew M; Peterson EA; Porath J
    Anal Biochem; 1985 Dec; 151(2):438-41. PubMed ID: 3879424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in the development of medical products based on human plasma.
    Josić D; Schulz P; Biesert L; Hoffer L; Schwinn H; Kordis-Krapez M; Strancar A
    J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):253-69. PubMed ID: 9252039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
    Edwards CA; Piet MP; Chin S; Horowitz B
    Vox Sang; 1987; 52(1-2):53-9. PubMed ID: 3111089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Elimination of lipoproteins, alpha 1 antitrypsin and complement activity of human serum after agitation with iso-amyl alcohol. A study with special reference to bidimensional immunoelectrophoresis].
    Badin J; Lajarrige S; Denne MA
    Ann Biol Clin (Paris); 1974; 32(6):533-40. PubMed ID: 4143242
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of plasma derivatives for clinical use.
    Tullis JL
    Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
    [No Abstract]   [Full Text] [Related]  

  • 40. Depletion of highly abundant proteins in blood plasma by hydrophobic interaction chromatography for proteomic analysis.
    Mahn A; Reyes A; Zamorano M; Cifuentes W; Ismail M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1038-44. PubMed ID: 20356804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.